[HTML][HTML] Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
Given the growing number of patients receiving direct oral anticoagulant (DOAC), patients
requiring rapid neutralization is also increasing in case of major bleedings or urgent …
requiring rapid neutralization is also increasing in case of major bleedings or urgent …
Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke—a single centre experience
E Włodarczyk, K Sawczyńska… - Neurologia i …, 2023 - journals.viamedica.pl
Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in
patients with acute ischaemic stroke — as Page 1 1 www.journals.viamedica.pl/neurologia_neurochirurgia_polska …
patients with acute ischaemic stroke — as Page 1 1 www.journals.viamedica.pl/neurologia_neurochirurgia_polska …
Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative Physician
A Giebler, R Sniecinski - Current Anesthesiology Reports, 2024 - Springer
Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative
Physician | Current Anesthesiology Reports Skip to main content SpringerLink Account …
Physician | Current Anesthesiology Reports Skip to main content SpringerLink Account …
Massive Transfusion/Hemorrhage Protocols Versus Goal-Directed Bleeding Management: Science Gone Eerie?
K Görlinger, PM Kapoor - Journal of Cardiac Critical Care TSS, 2024 - jcardcritcare.org
Key questions in bleeding management are “Why does my patient bleed?” and “How to fix
it?” To answer the first question, the high negative predictive value of viscoelastic testing can …
it?” To answer the first question, the high negative predictive value of viscoelastic testing can …
Reversal or Repletion Treatment Strategies and Outcomes of Patients With Major Bleeding Events Managed in the Emergency Department: Large Real-Life …
A Conti, M Leorin, IC Bogazzi, N Renzi… - Critical Pathways in …, 2024 - journals.lww.com
Objective: To verify the incidence of bleeding events in patients on ongoing anticoagulant
treatment in the real world and compare the results of different reversal or repletion …
treatment in the real world and compare the results of different reversal or repletion …
[PDF][PDF] Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice
B Karaszewski - Neurologia i Neurochirurgia Polska, 2023 - journals.viamedica.pl
The optimum treatment for acute ischaemic stroke in patients receiving active
anticoagulation, ie with effective levels of anticoagulant activity, which most commonly …
anticoagulation, ie with effective levels of anticoagulant activity, which most commonly …
A review on increasing risk for gastrointestinal bleeding associated with dabigatran.
Q Niu, G Yang, P Liu, Y Jiang - Signa Vitae, 2024 - search.ebscohost.com
Dabigatran, a reversible direct thrombin inhibitor, is widely used in clinical practice as a
therapeutic option due to its unique mechanism of action in comparison to other …
therapeutic option due to its unique mechanism of action in comparison to other …
Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
D Bozic, D Alicic, D Martinovic, I Zaja, J Bilandzic-Ivisic… - Medicina, 2023 - mdpi.com
Background and Objectives: Anticoagulants are a well-known risk factor for gastrointestinal
bleeding (GIB). In recent years, direct oral anticoagulants (DOACs) have taken a leading …
bleeding (GIB). In recent years, direct oral anticoagulants (DOACs) have taken a leading …
[引用][C] Intravenous thrombolysis following dabigatran reversal in a patient with acute embolic stroke after atrial fibrillation ablation
YS Chen, CY Lin - Journal of Arrhythmia, 2024 - Wiley Online Library
A 68-year-old male presented with intermittent palpitations and shortness of breath for 6
months. He has past medical history of paroxysmal atrial fibrillation (AF) with CHA2DS2 …
months. He has past medical history of paroxysmal atrial fibrillation (AF) with CHA2DS2 …